{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:03:13Z","timestamp":1790114593683,"version":"4.0.1"},"reference-count":51,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2014,6]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hyperbaric oxygen therapy (<jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content>) provides 100% oxygen under pressure, which increases tissue oxygen levels, relieves hypoxia and alters inflammatory pathways. Although there is experience using <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> in Crohn's disease and ulcerative colitis, the safety and overall efficacy of <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> in inflammatory bowel disease (<jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content>) is unknown.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To quantify the safety and efficacy of <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> for Crohn's disease (<jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>) and ulcerative colitis (<jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>). The rate of adverse events with <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> for <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> was compared to the expected rate of adverse events with <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">MEDLINE<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> EMBASE<\/jats:styled-content>, Cochrane Collaboration and Web of Knowledge were systematically searched using the <jats:styled-content style=\"fixed-case\">PRISMA<\/jats:styled-content> standards for systematic reviews. Seventeen studies involving 613 patients (286 <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>, 327 <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>) were included.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The overall response rate was 86% (85% <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>, 88% <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content>). The overall response rate for perineal <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content> was 88% (18\/40 complete healing, 17\/40 partial healing). Of the 40 <jats:styled-content style=\"fixed-case\">UC<\/jats:styled-content> patients with endoscopic follow\u2010up reported, the overall response rate to <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> was 100%. During the 8924 treatments, there were a total of nine adverse events, six of which were serious. The rate of adverse events with <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> is lower than that seen when utilising <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> for other indications (<jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.01). The risk of bias across studies was high.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Hyperbaric oxygen therapy is a relatively safe and potentially efficacious treatment option for <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content> patients. To understand the true benefit of <jats:styled-content style=\"fixed-case\">HBOT<\/jats:styled-content> in <jats:styled-content style=\"fixed-case\">IBD<\/jats:styled-content>, well\u2010controlled, blinded, randomised trials are needed for both Crohn's disease and ulcerative colitis.<\/jats:p><\/jats:sec>","DOI":"10.1111\/apt.12753","type":"journal-article","created":{"date-parts":[[2014,4,17]],"date-time":"2014-04-17T02:41:11Z","timestamp":1397702471000},"page":"1266-1275","source":"Crossref","is-referenced-by-count":87,"title":["Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease"],"prefix":"10.1111","volume":"39","author":[{"given":"P. S.","family":"Dulai","sequence":"first","affiliation":[{"name":"Inflammatory Bowel Disease Center Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"},{"name":"Center for Hyperbaric Medicine Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. W.","family":"Gleeson","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"},{"name":"Center for Hyperbaric Medicine Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Taylor","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. D.","family":"Holubar","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Buckey","sequence":"additional","affiliation":[{"name":"Center for Hyperbaric Medicine Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. A.","family":"Siegel","sequence":"additional","affiliation":[{"name":"Inflammatory Bowel Disease Center Dartmouth\u2010Hitchcock Medical Center Lebanon NH USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,4,16]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050516"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08512-4"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.10.032"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.01.035"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa067594"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.01.004"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.05.020"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31829aad16"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.01.021"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/21.10.1795"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00323.2007"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.03.027"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.193.9.1027"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000008633"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004210100391"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2000.278.5.E811"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2003.02248.x"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1027378532003"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2005.08.018"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200421086"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0b013e31828dcaaf"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.01992.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.01.056"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2003.08.024"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastro.2003.08.025"},{"key":"e_1_2_8_27_1","first-page":"119","article-title":"Complications and side effects of hyperbaric oxygen therapy","volume":"71","author":"Plafki C","year":"2000","journal-title":"Aviat Space Environ Med"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.12.048"},{"key":"e_1_2_8_29_1","first-page":"189","article-title":"Hyperbaric oxygen: a new alternative in the treatment of perianal Crohn's disease","volume":"51","author":"Sipahi AM","year":"1996","journal-title":"Rev Hosp Clin Fac Med Sao Paulo"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.03374.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(13)60411-9"},{"key":"e_1_2_8_32_1","first-page":"340","article-title":"Indications of hyperbaric oxygen for the treatment of severe ulcerative colitis? [French] Place De L'oxygene Hyperbare Dans Le Traitement Des Colites Ulcereuses Graves?","volume":"19","author":"Ben Bouali A","year":"1990","journal-title":"Medecine et Chirurgie Digestives"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200110000-00018"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200209000-00021"},{"key":"e_1_2_8_35_1","first-page":"632","article-title":"A different therapeutic approach in patients with severe ulcerative colitis: hyperbaric oxygen treatment","volume":"96","author":"Gurbuz AK","year":"2003","journal-title":"South Med J"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01540577"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)90649-5"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)95043-7"},{"key":"e_1_2_8_39_1","first-page":"201","article-title":"Efficacy of hyperbaric oxygen in patients with Crohn's disease: two case reports","volume":"40","author":"Green MS","year":"2013","journal-title":"Undersea Hyperb Med"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1590\/S0102-86502011000800024"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02054120"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199410000-00006"},{"key":"e_1_2_8_43_1","first-page":"78","article-title":"Hyperbaric oxygenation as a part of the treatment of chronic ulcerohemorrhagic colitis","volume":"30","author":"Karkumov M","year":"1991","journal-title":"Vutr Boles"},{"key":"e_1_2_8_44_1","first-page":"132","article-title":"Experience of preservation remission in inflammatory bowel diseases","volume":"9","author":"Grigor'eva GA","year":"2011","journal-title":"Eksp Klin Gastroenterol"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.3109\/00365521.2013.819443"},{"key":"e_1_2_8_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/nri2607"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202366109"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051047"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2006.78"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e3181fbe2bf"},{"key":"e_1_2_8_51_1","first-page":"123","article-title":"Effects of hyperoxia on neutrophil adhesion","volume":"31","author":"Thom SR","year":"2004","journal-title":"Undersea Hyperb Med"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/22.12.1979"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12753","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/apt.12753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T13:54:08Z","timestamp":1695563648000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,16]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.1111\/apt.12753"],"URL":"https:\/\/doi.org\/10.1111\/apt.12753","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,16]]}}}